Serialization Event for CMOs, CPOs and 3PLs
on 28 February 2017
Two interactive days in Princeton, NJ, aim to assist key pharmaceutical manufacturers, CMOs, CPOs and 3PL’s achieve cost-effective compliance with November DSCSA serialization deadline.
An April 4-5, 2017 Pharma CMO Summit hosted by Supply Chain Wizard will bring together manufacturers, CMOs, CPOs, 3PLs and solution providers for two days of education and interactive activities centered on serialization compliance, serialized operations and value beyond compliance. Although full implementation of the Drug Supply Chain Security Act will come in phases, the next milestone for manufacturers is November 27, 2017, by which date pharmaceutical manufacturers are required to print a unique product identification code on all prescription drug units of sale and homogenous cases distributed in the U.S.
With that in mind, one of the Summit’s main objectives is to provide late starters with flexible strategies and solutions for achieving the shortest path to compliance. Leading solutions on the market focused on fast, cost-effective implementation will be modeled, and case study presentations will help educate trading partners on likely challenges to implementing serialized operations.
Pharmaceutical manufacturers Abbott, Par Pharmaceutical and Teva, as well as providers Adents, Antares Vision and Verify Brand will sponsor the Summit, although additional sponsorship opportunities are available. The Pharma CMO Summit will be held at the Nassau Inn Hotel in Princeton, NJ.
Supply Chain Wizard is a global consulting firm specializing in serialization and traceability, as well as supply chain strategy and operational transformation programs. This event is supported by Pharma & Biopharma Outsourcing Association (PBOA), a national organization representing Contract Manufacturing Organizations and Contract Development and Manufacturing Organizations (CMOs/CDMOs) in the drug industry.
With only eight months to meet the Drug Supply Chain Security Act (DSCSA) serialization deadline, the gathering offers an opportunity for pharmaceutical industry partners to make or finalize strategies for both initial compliance and optimized post-implementation operations.
“By providing a forum that brings together perspectives from the full spectrum of supply chain partners, from manufacturers to dispensers, the Summit will not only help all players be best prepared for November’s deadline, but also lead to opportunities for valuable collaborations,” says Evren Ozkaya, Supply Chain Wizard’s CEO.